Hit-to-Lead Studies for the Antimalarial Tetrahydroisoquinolone Carboxanilides-Reference-Cited by-同舟云学术

Hit-to-Lead Studies for the Antimalarial Tetrahydroisoquinolone Carboxanilides

Published:2016-08-25 Issue:17 Volume:59 Page:7950-7962
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Floyd David M.¹,Stein Philip¹,Wang Zheng¹,Liu Jian¹,Castro Steve¹,Clark Julie A.²,Connelly Michele²,Zhu Fangyi²,Holbrook Gloria²,Matheny Amy²,Sigal Martina S.²,Min Jaeki²,Dhinakaran Rajkumar³,Krishnan Senthil³,Bashyum Sridevi³,Knapp Spencer¹,Guy R. Kiplin²

Affiliation:

1. Department of Chemistry & Chemical Biology, Rutgers The State University of New Jersey, 610 Taylor Road, Piscataway, New Jersey 08854 United States

2. Department of Chemical Biology and Therapeutics, St. Jude Children’s Research Hospital, 262 Danny Thomas Place, Memphis, Tennessee 38105 United States

3. Syngene International Ltd., Plot No. 2 & 3, Bommasandra IV Phase, Jigani Link Road, Bangalore, India 560 099

Funder

National Institute of Allergy and Infectious Diseases

Medicines for Malaria Venture

American Lebanese Syrian Associated Charities

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.6b00752

Reference24 articles.